The trademark application LEQSELVI was filed by Concert Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 5, 2021, and it was registered by office on December 14, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations except for cardiovascular diseases
Pharmaceutical preparations for the treatment of autoimmune, gastrointestinal, and inflammatory diseases and disorders
Pharmaceutical preparations for the treatment of skin disorders
Pharmaceutical preparations for the treatment of hair loss disorders